Showing 1 - 5 results of 5 for search 'Antonino Cassata', query time: 0.03s Refine Results
  1. 1
    Biotherapies in Solid Tumors: Are Negative Results Still of Low Priority for Publication?

    Biotherapies in Solid Tumors: Are Negative Results Still of Low Priority for Publication? by Alessandro Ottaiano, Antonino Cassata, Monica Capozzi, Chiara De Divitiis, Alfonso De Stefano, Antonio Avallone

    Published 2018-03-01
    Get full text
    Article
  2. 2
    Abbreviated MRI protocol for colorectal liver metastases: How the radiologist could work in pre surgical setting.

    Abbreviated MRI protocol for colorectal liver metastases: How the radiologist could work in pre surgical setting. by Vincenza Granata, Roberta Fusco, Antonio Avallone, Antonino Cassata, Raffaele Palaia, Paolo Delrio, Roberta Grassi, Fabiana Tatangelo, Giulia Grazzini, Francesco Izzo, Antonella Petrillo

    Published 2020-01-01
    Get full text
    Article
  3. 3
    Heterogeneous disease and intermittent treatment in metastatic colorectal cancer: A case report

    Heterogeneous disease and intermittent treatment in metastatic colorectal cancer: A case report by Alfonso De Stefano, Nicoletta Zanaletti, Antonino Cassata, Lucrezia Silvestro, Anna Nappi, Rossana Casaretti, Carmela Romano, Francesca Foschini, Claudia Cardone, Marco Borrelli, Antonella Petrillo, Alfredo Budillon, Paolo Delrio, Antonio Avallone

    Published 2023-02-01
    Get full text
    Article
  4. 4
    First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis

    First Biologic Drug in the Treatment of RAS Wild-Type Metastatic Colorectal Cancer: Anti-EGFR or Bevacizumab? Results From a Meta-Analysis by Alessandro Ottaiano, Alfonso De Stefano, Monica Capozzi, Anna Nappi, Chiara De Divitiis, Carmela Romano, Lucrezia Silvestro, Antonino Cassata, Rossana Casaretti, Salvatore Tafuto, Michele Caraglia, Massimiliano Berretta, Guglielmo Nasti, Antonio Avallone

    Published 2018-05-01
    Get full text
    Article
  5. 5
    Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol

    Cetuximab, irinotecan and fluorouracile in fiRst-line treatment of immunologically-selected advanced colorectal cancer patients: the CIFRA study protocol by Alessandro Ottaiano, Stefania Scala, Nicola Normanno, Maria Napolitano, Monica Capozzi, Anna Maria Rachiglio, Cristin Roma, Anna Maria Trotta, Crescenzo D’Alterio, Luigi Portella, Carmela Romano, Antonino Cassata, Rossana Casaretti, Lucrezia Silvestro, Anna Nappi, Salvatore Tafuto, Antonio Avallone, Alfonso De Stefano, Mario Tamburini, Carmine Picone, Antonella Petrillo, Francesco Izzo, Raffaele Palaia, Vittorio Albino, Alfonso Amore, Andrea Belli, Ugo Pace, Massimiliano Di Marzo, Paolo Chiodini, Gerardo Botti, Gianfranco De Feo, Paolo Delrio, Guglielmo Nasti

    Published 2019-09-01
    Get full text
    Article

Search Tools: